Development of interferon-gamma antagonists as an example of biotechnology application to approach new immunomodulators (Q38262538)

1 September 2017

1 reference

title

Development of interferon-gamma antagonists as an example of biotechnology application to approach new immunomodulators (English)

1 reference

1 September 2017

0 references

G Garotta

1

1 reference

1 September 2017

L Ozmen

series ordinal

2

1 reference

1 September 2017

M Fountoulakis

series ordinal

3

1 reference

1 September 2017

1 November 1989

1 reference

1 September 2017

Pharmacological Research

1 reference

1 September 2017

21 Suppl 2

1 reference

1 September 2017

5-17

1 reference

Molecular cloning lends credence to lymphokine research

1 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Peptide growth factors are multifunctional

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Role of aggregated human growth hormone (hGH) in development of antibodies to hGH

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Immune interferon: a pleiotropic lymphokine with multiple effects

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Role of γ-interferon in antibody-producing responses

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Interferon-gamma: the major mediator of resistance against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Functional identity between murine γ Interferon and macrophage activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Supergene families meet in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

In vivo effects of interferon-gamma and anti-interferon-gamma antibody on the experimentally induced lichenoid tissue reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Interferon in chronic polyarthritis. Positive effect in clinical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Functional heterogeneity of CD4+ T cells in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Gamma-interferon: the match that lights the fire?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Expression of human immune interferon cDNA in E. coli and monkey cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Structural characterization of human interferon gamma. Heterogeneity of the carboxyl terminus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

Molecular cloning and expression of the human interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2889%2980013-1

7 January 2021

10.1016/S1043-6618(89)80013-1

Identifiers

DOI

1 reference

release_gwwlwmo46zeuvmhfmrdbx4raq4

1 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gwwlwmo46zeuvmhfmrdbx4raq4

24 November 2022

mapped directly with Wikidata item

1 reference